多烯磷脂酰胆碱胶囊对原发性肝癌介入治疗效果和生存质量的影响

Effect of Polyene Phosphatidylcholine Capsule on Interventional Treatment and Quality of Life in Patients with Primary Liver Cancer

目的:分析多烯磷脂酰胆碱胶囊对原发性肝癌介入治疗效果和生存质量的影响。方法:选取2015年1月-2016年12月于笔者所在医院就诊的100例原发性肝癌(HCC)患者为研究对象,将其随机平均分为对照组和观察组。对照组患者采用传统的导管介入肝动脉化疗栓塞治疗,观察组患者在此基础上加用多烯磷脂酰胆碱胶囊治疗。比较分析两组患者的治疗效果和生存质量。结果:观察组患者临床治疗总有效率及生存质量评分明显优于对照组,差异均有统计学意义(P<0.05)。结论:针对原发性肝癌患者采用多烯磷脂酰胆碱胶囊治疗,能够显著改善患者肝功能,提高患者的生存质量,是一种有效的治疗方式,应用价值高。

Objective： To study the effect of Polyene Phosphatidylcholine Capsule on interventional treatment and quality of life in patients with primary liver cancer.Method： From January 2015 to December 2016, 100 patients with primary hepatocellular carcinoma（HCC） were selected as the study subjects, and the patients were randomly divided into control group and observation group.The control group was treated by traditional catheter intervention hepatic artery embolism chemotherapy treatment; on this basis, the observation group received combined with Polyene Phosphatidylcholine Capsule treatment.The therapeutic effect and survival quality of the two groups were compared.Result： The clinical therapeutic total effect rate and quality of life scores in the observation group were significantly better than those in the control group, the differences were statistically significant（P〈0.05）.Conclusion： The patients with primary liver cancer received Polyene Phosphatidylcholine Capsule treatment, can significantly improve liver function and quality of life, and has high application value.